TY - JOUR
T1 - Maximizing adherence and retention for women living with HIV and their infants in Kenya (MOTIVATE! study)
T2 - Study protocol for a randomized controlled trial
AU - Odeny, Thomas A.
AU - Onono, Maricianah
AU - Owuor, Kevin
AU - Helova, Anna
AU - Wanga, Iris
AU - Bukusi, Elizabeth A.
AU - Turan, Janet M.
AU - Abuogi, Lisa L.
N1 - Funding Information:
The MOTIVATE! study is supported by Award Number R01HD080477 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (USA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICHD t or the NIH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2018 The Author(s).
PY - 2018/1/29
Y1 - 2018/1/29
N2 - Background: Successful completion and retention throughout the multi-step cascade of prevention of mother-to-child HIV transmission (PMTCT) remains difficult to achieve. The Mother and Infant Visit Adherence and Treatment Engagement study aims to evaluate the effect of mobile text messaging, community-based mentor mothers (cMMs), or both on increasing antiretroviral therapy (ART) adherence, retention in HIV care, maternal viral load suppression, and mother-to-child HIV transmission for mother-infant pairs receiving lifelong ART. Methods/design: This study is a cluster randomized, 2 × 2 factorial, controlled trial. The trial will be undertaken in the western Kenyan counties of Migori, Kisumu, and Homa Bay. Study sites will be randomized into one of four groups: six sites will implement both text messaging and cMM, six sites will implement cMM only, six sites will implement text messaging only, and six sites will implement the existing standard of care. The primary analysis will be based on the intention-to-treat principle and will compare maternal ART adherence and maternal retention in care. Discussion: This study will determine the impact of long-term (up to 12 months postpartum) text messaging and cMMs on retention in and adherence to ART among pregnant and breastfeeding women living with HIV in Kenya. It will address key gaps in our understanding of what interventions may successfully promote long-term retention in the PMTCT cascade of care.
AB - Background: Successful completion and retention throughout the multi-step cascade of prevention of mother-to-child HIV transmission (PMTCT) remains difficult to achieve. The Mother and Infant Visit Adherence and Treatment Engagement study aims to evaluate the effect of mobile text messaging, community-based mentor mothers (cMMs), or both on increasing antiretroviral therapy (ART) adherence, retention in HIV care, maternal viral load suppression, and mother-to-child HIV transmission for mother-infant pairs receiving lifelong ART. Methods/design: This study is a cluster randomized, 2 × 2 factorial, controlled trial. The trial will be undertaken in the western Kenyan counties of Migori, Kisumu, and Homa Bay. Study sites will be randomized into one of four groups: six sites will implement both text messaging and cMM, six sites will implement cMM only, six sites will implement text messaging only, and six sites will implement the existing standard of care. The primary analysis will be based on the intention-to-treat principle and will compare maternal ART adherence and maternal retention in care. Discussion: This study will determine the impact of long-term (up to 12 months postpartum) text messaging and cMMs on retention in and adherence to ART among pregnant and breastfeeding women living with HIV in Kenya. It will address key gaps in our understanding of what interventions may successfully promote long-term retention in the PMTCT cascade of care.
KW - Community mentor mothers
KW - HIV
KW - Option B+
KW - PMTCT
KW - SMS
KW - Text messages
UR - http://www.scopus.com/inward/record.url?scp=85041207677&partnerID=8YFLogxK
U2 - 10.1186/s13063-018-2464-3
DO - 10.1186/s13063-018-2464-3
M3 - Article
C2 - 29378622
AN - SCOPUS:85041207677
SN - 1745-6215
VL - 19
JO - Trials
JF - Trials
IS - 1
M1 - 77
ER -